Clinical Trials

1 studies in Orthostatic or postural hypotension

1. Droxidopa / Pyridostigmine in Orthostatic Hypotension Rochester, MN View Summary
   Close

   Droxidopa / Pyridostigmine in Orthostatic Hypotension

   Location:

   Rochester, MN

   Trial status:

   Open for Enrollment

   Why is this study being done?

   The hypothesis is that pyridostigmine will improve the safety factor of ganglionic neural transmission, while Droxidopa will replete the postganglionic neuron of norepinephrine (NE). This combination should result in enhanced orthostatic release of NE. The investigators have already demonstrated that pyridostigmine does not raise supine blood pressure.

   NCT ID:

   NCT01370512

   IRB Number:

   10-008810

   • Print Summary
   • View study details

   Who can I contact for additional information about this study?

   Rochester: Tonette Gehrking 507-284-0336